Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis

被引：0
|
作者：
Hirshberg, Boaz
Bryzinski, Brian
Xu, John
Monyak, John
Iqbal, Nayyar
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2403-PO
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Saxagliptin Added to Insulin With or Without Metformin in Chinese Patients with Type 2 Diabetes
    Chen, Yingli
    Liu, Xiaomin
    Li, Quanmin
    Ma, Jianhua
    Lv, Xiaofeng
    Guo, Lixin
    Wang, Changjiang
    Shi, Yongquan
    Li, Yanbing
    Johnsson, Eva
    Wang, Mei
    Zhao, June
    Ji, Linong
    DIABETES, 2017, 66 : A329 - A329
  • [32] Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes
    Rosenstock, J.
    Aguilar-Salinas, C.
    Klein, E.
    Nepal, S.
    List, J.
    Chen, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (10) : 2401 - 2411
  • [33] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    DIABETES, 2012, 61 : A260 - A260
  • [34] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [35] Safety and tolerability of sitagliptin in patients with type 2 diabetes: A pooled analysis
    Williams-Herman D.
    Round E.
    Swern A.S.
    Musser B.
    Davies M.J.
    Stein P.P.
    Kaufman K.D.
    Amatruda J.M.
    BMC Endocrine Disorders, 8 (1)
  • [36] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease History or Cardiovascular Risk Factors: Results of a Pooled Analysis of Phase 3 Clinical Trials
    Cook, William
    Bryzinski, Brian
    Slater, Jill
    Frederich, Robert
    Allen, Elsie
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 145 - 154
  • [37] Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies
    Liu, Jie
    Tarasenko, Lisa
    Terra, Steven G.
    Huyck, Susan
    Wu, Larry
    Pong, Annpey
    Calle, Roberto A.
    Gallo, Silvina
    Darekar, Amanda
    Mancuso, James P.
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05): : 415 - 423
  • [38] Saxagliptin improves glycaemic control as monotherapy in type 2 diabetes
    List, J.
    Rosenstock, J.
    Sankoh, S.
    Chen, R.
    DIABETOLOGIA, 2007, 50 : S367 - S367
  • [39] Efficacy and Safety of Rivoglitazone as Monotherapy for Type 2 Diabetes Mellitus
    Chou, Hubert S.
    Moberly, James
    Mun, Yong
    Choi, Youngsook
    Merante, Domenico
    Truitt, Kenneth E.
    DIABETES, 2010, 59 : A183 - A183
  • [40] EFFICACY AND SAFETY OF SAXAGLIPTIN, DIPEPTIDYL PEPTIDASE-4 INHIBITOR, IN HEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES
    Abe, M.
    Otsuki, T.
    Maruyama, N.
    Oikawa, O.
    Okada, K.
    NEPHROLOGY, 2016, 21 : 65 - 65
12345